Yıl: 2022 Cilt: 33 Sayı: 11 Sayfa Aralığı: 964 - 970 Metin Dili: İngilizce DOI: 10.5152/tjg.2022.21822 İndeks Tarihi: 25-05-2023

Healthcare-Related HCV Genotype 4d Infections in Kayseri, Turkey

Öz:
Background: The frequency of genotype 4 hepatitis C virus infection is significantly higher in a city compared to other provinces in Turkey. In this study, we aimed to investigate the epidemiology and risk factors of hepatitis C virus genotype 4 infection in Kayseri province of Turkey. Methods: A case–control study was conducted with 61 hepatitis C virus genotype 4-infected patients and 71 controls. A questionnaire was administered to the patients and controls, asking for information about the risk factors of hepatitis C virus transmission. Core/ E1 and NS5B regions of hepatitis C virus genome were amplified and sequenced by Sanger method. Phylogenetic analysis and molecular clock analysis were performed. The risk was determined by calculating the odds ratio and 95% CI. Logistic regression analysis was per- formed to determine the effect of risk factors by controlling for confounding variables. Results: Kayseri isolates were closely related to type 4d sequences but formed a separate cluster. According to the molecular clock analysis, hepatitis C virus genotype 4d entered Kayseri province probably between 1941 and 1988. Blood transfusion and surgical inter- vention were found to be significant risk factors for the infection. Conclusion: Epidemiological data showed that hepatitis C virus genotype 4d infections are significantly associated with unsafe medical procedures.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
0
0
0
  • 1. Forman MS, Valsamakis A. Hepatitis C virus. In: Jorgensen J, Pfaller M, Carroll K, et al., eds. Manual of Clinical Microbiology. 11th ed. Washington DC: ASM Press; 2015.
  • 2. Smith DB, Bukh J, Kuiken C, et al. Expanded classification of hepa titis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology. 2014;59(1):318- 327. [CrossRef]
  • 3. Borgia SM, Hedskog C, Parhy B, et al. Identification of a novel hepatitis C virus genotype From Punjab, India: expanding classifica tion of hepatitis C virus Into 8 genotypes. J Infect Dis. 2018;218(11):1722-1729. [CrossRef]
  • 4. Abacioglu YH, Davidson F, Tuncer S, et al. The distribution of hep atitis C virus genotypes in Turkish patients. J Viral Hepat. 1995;2(6):297-301. [CrossRef]
  • 5. Keskın F, Çiftçi S, Türkoǧlu S, Badur S. Transmission routes of chronic hepatitis C and their relation to HCV genotypes. Turk J Gas troenterol. 2010;21(4):396-400. [CrossRef]
  • 6. Barut S, Erkorkmaz U, Yüce S, Uyetürk U. Analysis of risk factors in anti-HCV positive patients in Gaziosmanpasa University Hospital, Tokat, Turkey. Mikrobiyol Bul. 2008;42(4):675-680.
  • 7. Kuşçu F, Kömür S, İnal AS, et al. Changing epidemiology of chronic hepatitis C in Adana. vhd. 2014;20(1):15-18. [CrossRef]
  • 8. Caliskan A, Kirisci O, Ozkaya E, et al. Distribution and predomi nance of genotype 3 in hepatitis C virus carriers in the province of Kahramanmaras, Turkey. Hepat Mon. 2015;15(4):e25142. [CrossRef]
  • 9. Kayman T, Karakükçü Ç, Karaman A, Gözütok F. Genotypic distri bution of hepatitis C virus infection in Kayseri region. J Turk Microbiol Soc. 2012;42:21-26.
  • 10. Gökahmetoğlu S, Atalay M, Kılınç A. Determination of hepatitis C virus genotypes with pyrosequencing method. Erciyes Med J. 2011;33(2):99-102.
  • 11. Roulot D, Bourcier V, Grando V, et al. Epidemiological character istics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection. J Viral Hepat. 2007;14(7):460- 467. [CrossRef]
  • 12. De Bruijne J, Schinkel J, Prins M, et al. Emergence of hepatitis C virus genotype 4: phylogenetic analysis reveals three distinct epidemiologi cal profiles. J Clin Microbiol. 2009;47(12):3832-3838. [CrossRef]
  • 13. Murphy DG, Willems B, Deschênes M, Hilzenrat N, Mousseau R, Sabbah S. Use of sequence analysis of the NS5B region for routine genotyping of hepatitis C virus with reference to C/E1 and 5′ untranslated region sequences. J Clin Microbiol. 2007;45(4):1102- 1112. [CrossRef]
  • 14. Laperche S, Lunel F, Izopet J, et al. Comparison of hepatitis C virus NS5b and 5′ noncoding gene sequencing methods in a multi center study. J Clin Microbiol. 2005;43(2):733-739. [CrossRef]
  • 15. Ciccozzi M, Zehender G, Polat C, et al. Phylogenetic analysis of HCV-4d in Turkey: the curious case of Kayseri Province. J Med Virol. 2014;86(3):454-460. [CrossRef]
  • 16. Kayman T, Polat C, Ergör G, Abacioğlu YH. Characterization of HCV genotype 4d infections in Kayseri, Turkey. Turk J Med Sci. 2015;45(3):547-552. [CrossRef]
  • 17. Kuiken C, Yusim K, Boykin L, Richardson R. The Los Alamos hepa titis C sequence database. Bioinformatics. 2005;21(3):379-384. [CrossRef]
  • 18. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 2011;28(10):2731-2739. [CrossRef]
  • 19. Yuan M, Lu T, Li C, Lu L. The evolutionary rates of HCV estimated with subtype 1a and 1b sequences over the ORF length and in dif ferent genomic regions. PLoS One. 2013;8(6):e64698. [CrossRef]
  • 20. Gray RR, Parker J, Lemey P, Salemi M, Katzourakis A, Pybus OG. The mode and tempo of hepatitis C virus evolution within and among hosts. BMC Evol Biol. 2011;11:131. [CrossRef]
  • 21. IBM Corp. IBM SPSS Statistics for Windows, Version 20.0; 2011. Armonk, NY: IBM Corp.
  • 22. Yildirim B, Tahan V, Ozaras R, et al. Hepatitis C virus risk factors in the Turkish community. Dig Dis Sci. 2005;50(12):2352-2355. [CrossRef]
  • 23. Hand WL, Vasquez Y. Risk factors for hepatitis C on the Texas Mexico border. Am J Gastroenterol. 2005;100(10):2180-2185. [CrossRef]
  • 24. Murphy EL, Bryzman SM, Glynn SA, et al. Risk factors for hepatitis C virus infection in united states blood donors. NHLBI Retrovirus Epi demiology Donor Study (REDS). Hepatology. 2000;31(3):756-762. [CrossRef]
  • 25. Acar A, Kemahli S, Altunay H, et al. HBV, HCV and HIV seropreva lence among blood donors in Istanbul, Turkey: how effective are the changes in the national blood transfusion policies? Braz J Infect Dis. 2010;14(1):41-46.
  • 26. Cantaloube JF, Gallian P, Laperche S, et al. Molecular characteri zation of genotype 2 and 4 hepatitis C virus isolates in French blood donors. J Med Virol. 2008;80(10):1732-1739. [CrossRef]
  • 27. Ciccozzi M, Equestre M, Costantino A, et al. Hepatitis C virus genotype 4d in Southern Italy: reconstruction of its origin and spread by a phylodynamic analysis. J Med Virol. 2012;84(10):1613-1619. [CrossRef]
  • 28. Magiorkinis G, Magiorkinis E, Paraskevis D, et al. The global spread of hepatitis C virus 1a and 1b: A phylodynamic and phylogeographic analysis. PLoS Med. 2009;6(12):e1000198. [CrossRef]
  • 29. Kendrick DB. Hospital center merger in Europe designed for bet ter patient care. Mil Med. 1964;129:230-234. [CrossRef]
APA gökahmetoğlu s, Polat C, Atalay M, Can Sezgin G, Ergör G, Aygen B, Gürsoy S, Abacioglu H (2022). Healthcare-Related HCV Genotype 4d Infections in Kayseri, Turkey. , 964 - 970. 10.5152/tjg.2022.21822
Chicago gökahmetoğlu selma,Polat Ceylan,Atalay Mustafa Altay,Can Sezgin Gülten,Ergör Gül,Aygen Bilgehan,Gürsoy Sebnem,Abacioglu Hakan Healthcare-Related HCV Genotype 4d Infections in Kayseri, Turkey. (2022): 964 - 970. 10.5152/tjg.2022.21822
MLA gökahmetoğlu selma,Polat Ceylan,Atalay Mustafa Altay,Can Sezgin Gülten,Ergör Gül,Aygen Bilgehan,Gürsoy Sebnem,Abacioglu Hakan Healthcare-Related HCV Genotype 4d Infections in Kayseri, Turkey. , 2022, ss.964 - 970. 10.5152/tjg.2022.21822
AMA gökahmetoğlu s,Polat C,Atalay M,Can Sezgin G,Ergör G,Aygen B,Gürsoy S,Abacioglu H Healthcare-Related HCV Genotype 4d Infections in Kayseri, Turkey. . 2022; 964 - 970. 10.5152/tjg.2022.21822
Vancouver gökahmetoğlu s,Polat C,Atalay M,Can Sezgin G,Ergör G,Aygen B,Gürsoy S,Abacioglu H Healthcare-Related HCV Genotype 4d Infections in Kayseri, Turkey. . 2022; 964 - 970. 10.5152/tjg.2022.21822
IEEE gökahmetoğlu s,Polat C,Atalay M,Can Sezgin G,Ergör G,Aygen B,Gürsoy S,Abacioglu H "Healthcare-Related HCV Genotype 4d Infections in Kayseri, Turkey." , ss.964 - 970, 2022. 10.5152/tjg.2022.21822
ISNAD gökahmetoğlu, selma vd. "Healthcare-Related HCV Genotype 4d Infections in Kayseri, Turkey". (2022), 964-970. https://doi.org/10.5152/tjg.2022.21822
APA gökahmetoğlu s, Polat C, Atalay M, Can Sezgin G, Ergör G, Aygen B, Gürsoy S, Abacioglu H (2022). Healthcare-Related HCV Genotype 4d Infections in Kayseri, Turkey. Turkish Journal of Gastroenterology, 33(11), 964 - 970. 10.5152/tjg.2022.21822
Chicago gökahmetoğlu selma,Polat Ceylan,Atalay Mustafa Altay,Can Sezgin Gülten,Ergör Gül,Aygen Bilgehan,Gürsoy Sebnem,Abacioglu Hakan Healthcare-Related HCV Genotype 4d Infections in Kayseri, Turkey. Turkish Journal of Gastroenterology 33, no.11 (2022): 964 - 970. 10.5152/tjg.2022.21822
MLA gökahmetoğlu selma,Polat Ceylan,Atalay Mustafa Altay,Can Sezgin Gülten,Ergör Gül,Aygen Bilgehan,Gürsoy Sebnem,Abacioglu Hakan Healthcare-Related HCV Genotype 4d Infections in Kayseri, Turkey. Turkish Journal of Gastroenterology, vol.33, no.11, 2022, ss.964 - 970. 10.5152/tjg.2022.21822
AMA gökahmetoğlu s,Polat C,Atalay M,Can Sezgin G,Ergör G,Aygen B,Gürsoy S,Abacioglu H Healthcare-Related HCV Genotype 4d Infections in Kayseri, Turkey. Turkish Journal of Gastroenterology. 2022; 33(11): 964 - 970. 10.5152/tjg.2022.21822
Vancouver gökahmetoğlu s,Polat C,Atalay M,Can Sezgin G,Ergör G,Aygen B,Gürsoy S,Abacioglu H Healthcare-Related HCV Genotype 4d Infections in Kayseri, Turkey. Turkish Journal of Gastroenterology. 2022; 33(11): 964 - 970. 10.5152/tjg.2022.21822
IEEE gökahmetoğlu s,Polat C,Atalay M,Can Sezgin G,Ergör G,Aygen B,Gürsoy S,Abacioglu H "Healthcare-Related HCV Genotype 4d Infections in Kayseri, Turkey." Turkish Journal of Gastroenterology, 33, ss.964 - 970, 2022. 10.5152/tjg.2022.21822
ISNAD gökahmetoğlu, selma vd. "Healthcare-Related HCV Genotype 4d Infections in Kayseri, Turkey". Turkish Journal of Gastroenterology 33/11 (2022), 964-970. https://doi.org/10.5152/tjg.2022.21822